| Lastest Insider Transactions Of ANI PHARMACEUTICALS INC ( ANIP ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-18 | Sell | 27,232 | 65.10 | 1,772,729 | 2024-04-22 18:26:41 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-15 | Sell | 22,768 | 65.91 | 1,500,589 | 2024-04-17 16:33:11 |
| ANIP | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-04-12 | Sell | 250 | 67.79 | 16,948 | 2024-04-15 18:28:48 |
| ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-04-01 | Sell | 20,000 | 67.25 | 1,345,000 | 2024-04-02 18:59:16 |
| ANIP | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-03-13 | Sell | 250 | 66.54 | 16,635 | 2024-03-13 16:48:18 |
| ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-03-11 | Sell | 20,000 | 65.81 | 1,316,200 | 2024-03-13 16:44:44 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-08 | Sell | 10,000 | 67.17 | 671,700 | 2024-03-11 18:43:20 |
| ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | 2024-03-07 | Sell | 7,787 | 65.55 | 510,438 | 2024-03-11 18:39:53 |
| ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | 2024-03-06 | Sell | 45,257 | 66.10 | 2,991,469 | 2024-03-08 19:25:12 |
| ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | 2024-03-07 | Sell | 24,338 | 66.37 | 1,615,313 | 2024-03-07 21:42:07 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-05 | Sell | 40,000 | 65.77 | 2,630,864 | 2024-03-07 21:11:59 |
| ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | 2024-03-05 | Sell | 5,000 | 66.00 | 330,000 | 2024-03-06 16:24:34 |
| ANIP | ANI PHARMACEUTICALS INC | Pera Antonio R | Directior | 2024-03-04 | Sell | 7,000 | 65.20 | 456,400 | 2024-03-06 16:20:36 |
| ANIP | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-02-13 | Sell | 250 | 56.04 | 14,010 | 2024-02-13 20:05:24 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-19 | Sell | 25,216 | 56.17 | 1,416,466 | 2024-01-23 17:32:18 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-16 | Sell | 24,784 | 55.29 | 1,370,305 | 2024-01-18 18:20:10 |
| ANIP | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-01-12 | Sell | 250 | 56.43 | 14,108 | 2024-01-16 21:09:14 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-12-15 | Sell | 50,000 | 52.55 | 2,627,250 | 2023-12-19 17:44:21 |
| ANIP | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2023-12-11 | Sell | 250 | 49.21 | 12,303 | 2023-12-11 17:49:06 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-17 | Sell | 13,000 | 51.00 | 663,000 | 2023-11-20 21:05:59 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-14 | Sell | 37,000 | 53.00 | 1,961,148 | 2023-11-20 20:58:10 |
| ANIP | ANI PHARMACEUTICALS INC | Davis Krista | SVP, CHIEF HR OFFICER | 2023-11-15 | Sell | 2,622 | 53.81 | 141,090 | 2023-11-16 18:13:34 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-14 | Sell | 36,190 | 53.00 | 1,918,080 | 2023-11-16 18:11:17 |
| ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | 2023-11-10 | Sell | 3,000 | 52.47 | 157,410 | 2023-11-13 16:02:30 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-17 | Sell | 25,000 | 57.75 | 1,443,869 | 2023-10-19 16:28:35 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-13 | Sell | 25,000 | 57.96 | 1,449,036 | 2023-10-17 16:32:09 |
| ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-10-02 | Sell | 20,000 | 56.48 | 1,129,600 | 2023-10-03 20:00:20 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-09-15 | Sell | 50,000 | 61.81 | 3,090,617 | 2023-09-19 17:14:55 |
| ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-09-01 | Sell | 20,000 | 64.70 | 1,294,000 | 2023-09-05 17:06:01 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-28 | Sell | 50,000 | 63.22 | 3,160,750 | 2023-08-30 16:29:01 |
| ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | 2023-08-23 | Sell | 15,561 | 62.39 | 970,851 | 2023-08-25 16:22:42 |
| ANIP | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | 2023-08-23 | Option Exercise | 13,502 | 31.49 | 425,178 | 2023-08-25 16:22:42 |
| ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | 2023-08-23 | Sell | 3,932 | 63.00 | 247,716 | 2023-08-25 16:17:55 |
| ANIP | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | 2023-08-23 | Option Exercise | 5,417 | 38.25 | 207,224 | 2023-08-25 16:17:55 |
| ANIP | ANI PHARMACEUTICALS INC | MERIDIAN VENTURE PARTNERS II LP | 10% Owner | 2023-08-16 | Sell | 200,000 | 58.50 | 11,700,000 | 2023-08-16 20:00:20 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-14 | Sell | 50,000 | 61.35 | 3,067,450 | 2023-08-16 19:07:03 |
| ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | 2023-08-14 | Sell | 17,639 | 61.37 | 1,082,505 | 2023-08-16 16:24:24 |
| ANIP | ANI PHARMACEUTICALS INC | Pera Antonio R | Directior | 2023-08-14 | Sell | 3,000 | 60.37 | 181,110 | 2023-08-15 20:45:44 |
| ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | 2023-08-11 | Sell | 68,282 | 58.32 | 3,982,548 | 2023-08-15 20:39:03 |
| ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | 2023-08-11 | Option Exercise | 11,616 | 29.00 | 336,864 | 2023-08-15 20:39:03 |
| ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-08-01 | Sell | 20,000 | 51.06 | 1,021,200 | 2023-08-03 18:03:26 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-19 | Sell | 23,469 | 52.02 | 1,220,844 | 2023-07-21 19:15:47 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-14 | Sell | 26,531 | 51.02 | 1,353,599 | 2023-07-18 20:06:26 |
| ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-07-03 | Sell | 20,000 | 53.43 | 1,068,600 | 2023-07-06 16:15:33 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-20 | Sell | 50,000 | 51.70 | 2,584,912 | 2023-06-23 20:01:27 |
| ANIP | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-06-22 | Sell | 20,000 | 51.32 | 1,026,400 | 2023-06-23 20:00:34 |
| ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-20 | Sell | 40,000 | 51.75 | 2,070,012 | 2023-06-22 20:00:12 |
